Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorRAHERISON, Chantal
dc.contributor.authorAGUILANIU, Bernard
dc.contributor.authorZYSMAN, Maeva
dc.contributor.authorBURGEL, Pierre-Regis
dc.contributor.authorHESS, David
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorOUAALAYA, El Hassane
dc.contributor.authorTRAN, Thi Chien
dc.contributor.authorROCHE, Nicolas
dc.contributor.authorINVESTIGATORS FROM COLIBRI, Initiatives Bpco
dc.contributor.authorCOHORTS, Palomb
dc.date.accessioned2024-08-20T13:51:15Z
dc.date.available2024-08-20T13:51:15Z
dc.date.issued2024-06-03
dc.identifier.issn2590-0412en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/201201
dc.description.abstractEnBACKGROUND: Low vaccination rates against influenza and Streptococcus (S.) pneumoniae infections in COPD could impair outcomes. Understanding underlying factors could help improving implementation. OBJECTIVES: To describe vaccination rates at inclusion in COPD cohorts and analyze associated factors. METHODS: Between 2012 and 2018, 5927 patients with sufficient data available were recruited in 3 French COPD cohorts (2566 in COLIBRI-COPD, 2653 in PALOMB and 708 in Initiatives BPCO). Data at inclusion were pooled to describe vaccination rates and analyze associated factors. RESULTS: Mean age was 66 years, 34 % were women, 35 % were current smokers, mean FEV1 was 58 % predicted, 22 % reported ≥2 exacerbations in the year prior to inclusion, mMRC dyspnea grade was ≥2 in 59 %, 52 % had cardiovascular comorbidities and 9 % a history of asthma. Vaccinations rates in the year prior to study entry were 34.4 % for influenza + S. pneumoniae, 17.5 % for influenza alone and 8.9 % for S. pneumoniae alone. In multivariate analyses, influenza vaccination rate was greater in older age, smoking status, low FEV1, exacerbation history, mMRC dyspnea>2, asthma history, hypertension, diabetes mellitus, and the year of inclusion. SP vaccination was associated with type of practice of the respiratory physician, age, smoking status, FEV1, exacerbation history, dyspnea grade, asthma history and the year of inclusion. CONCLUSION: Rates of vaccination against influenza and S. pneumoniae infection at inclusion in COPD cohorts remain insufficient and vaccination appears restricted to patients with specific features especially regarding severity and comorbidities, which is not consistent with current recommendations.
dc.language.isoENen_US
dc.subject.enCOPD
dc.subject.enInfluenza
dc.subject.enSeverity
dc.subject.enStreptococcus pneumoniae
dc.subject.enVaccination
dc.title.enInfluenza and pneumococcal vaccination in patients with COPD from 3 French cohorts: Insufficient coverage and associated factors
dc.title.alternativeRespir Med Resen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.resmer.2024.101112en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed38901323en_US
bordeaux.journalRespiratory Medicine and Researchen_US
bordeaux.page101112en_US
bordeaux.volume86en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamEPICENE_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-04673839
hal.version1
hal.date.transferred2024-08-20T13:51:17Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Respiratory%20Medicine%20and%20Research&rft.date=2024-06-03&rft.volume=86&rft.spage=101112&rft.epage=101112&rft.eissn=2590-0412&rft.issn=2590-0412&rft.au=RAHERISON,%20Chantal&AGUILANIU,%20Bernard&ZYSMAN,%20Maeva&BURGEL,%20Pierre-Regis&HESS,%20David&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée